Intrinsic sensory deprivation induced by neonatal capsaicin treatment induces changes in rat brain and behaviour of possible relevance to schizophrenia

British Journal of Pharmacology

Volumn 146, Issue 3, 2005, Pages 408-418

  Newson, Penny ^a,b   Lynch Frame, Ann ^a,b   Roach, Rebecca ^a,b   Bennett, Sarah ^a,b   Carr, Vaughan ^a,b   Chahl, Loris A ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b Neuroscience Institute of Schizophrenia and Allied Disorders   (Australia)

Author keywords

Capsaicin; Neonatal capsaicin; Neuronal density; Rat behaviour; Rat brain; Schizophrenia; Sensory deprivation

Indexed keywords

CAPSAICIN; HALOPERIDOL; NICOTINIC ACID;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN AQUEDUCT; BRAIN TISSUE; BRAIN VENTRICLE; CELL DENSITY; CONTROLLED STUDY; CORPUS CALLOSUM; FEMALE; HIPPOCAMPUS; HISTOLOGY; HYPERACTIVITY; HYPOALGESIA; MUSCLE SPINDLE AFFERENT NERVE; NERVE CELL; NEUROPATHOLOGY; NEUROTOXICITY; NEWBORN; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORY DEPRIVATION; SEX DIFFERENCE; SOMATOSENSORY SYSTEM; VISUAL CORTEX;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BRAIN; CAPSAICIN; CELL COUNT; FEMALE; MALE; NEURONS; ORGAN SIZE; RATS; RATS, WISTAR; SCHIZOPHRENIA; SENSORY DEPRIVATION; SEX FACTORS; TAIL;

EID: 27144549707     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706349     Document Type: Article

References (54)

1. AL-HAYANI, A., WEASE, K.N., ROSS, R.A., PERTWEE, R.G. & DAVIES, S.N. (2001). The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology, 41, 1000-1005.
2. ARNOLD, S.E., TALBOT, K. & HAHN, C.G. (2005). Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Prog. Brain Res., 147, 319-345.
3. ASHE, P.C., BERRY, M.D. & BOULTON, A.A. (2001). Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 25, 691-707.
4. BEASLEY, C.L., CHANA, G., HANOVER, M., LANDAU, S., EVERALL, I.P. & COTTER, D. (2005). Evidence for altered neuronal organisation within the planum temporale in major psychiatric disorders. Schizophrenia Res., 73, 69-78.
5. BLUMENSOHN, R., RINGLER, D. & ELI, I. (2002). Pain perception in patients with schizophrenia. J. Nerv. Mental Dis., 190, 481-483.
6. BUXHOEVEDEN, D., ROY, E. & SWITALA, A. (2000). Reduced interneuronal space in schizophrenia. Biol. Psychiatry, 47, 681-683.
7. CASANOVA, M.F., DE ZEEUW, L, SWITALA, A., KRECZMANSKI, P., KORR, H., ULFIG, N., HEINSEN, H., STEINBUSCH, H.W.M. & SCHMITZ, C. (2005). Mean cell spacing abnormalities in the neocortex of patients with schizophrenia. Psychiatry Res., 133, 1-12.
8. CATERINA, M.J., SCHUMACHER, M.A., TOMINAGA, M., ROSEN, T.A., LEVINE, J.D. & JULIUS, D. (1997). The capsaicin receptor: a heat activated ion channel in the pain pathway. Nature, 389, 816-824.
9. CATERINA, M.J. & JULIUS, D. (2001). The vanilloid receptor: a molecular gateway to the pain pathway. Ann. Rev. Neurosci., 24, 487-517.
10. CHANA, G., LANDAU, S., BEASLEY, C., EVERALL, I.P. & COTTER, D. (2003). Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol. Psychiatry, 53, 1086-1098.
11. DE HERT, M. & ELLENBROEK, B. (2000). Animal models of schizophrenia. Neurosci. Res. Commun., 26, 279-288.
12. FROST, D.O., TAMMINGA, C.A., MEDOFF, D.R., CAVINESS, V., INNOCENTI, G. & CARPENTER, W.T. (2004). Neuroplasticity and schizophrenia. Biol. Psychiatry, 56, 540-543.
13. GERRITS, M.A.F.M., WOLTERINK, G., DAENEN, E.W.P.M. & VAN REE, J.M. (2002). Animal models of schizophrenia as a neurodevelopmental disorder. Eur. Neuropsychopharmacol., 12 (Suppl 3), 112-113.
14. HARRISON, P.J. (1997). Schizophrenia: a disorder of neurodevelopment. Curr. Opin. Neurobiol., 7, 285-289.
15. HOLZER, P. (1991). Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol. Rev., 43, 143-201.
16. HOOLEY, J.M. & DELGADO, M.L. (2001). Pain insensitivity in the relatives of schizophrenia patients. Schizophrenia Res., 47, 265-273.
17. HORI, T., SHIBATA, M., KIYOHARA, T., NAKASHIMA, T. & ASAMI, A. (1988). Responses of anterior hypothalamic-preoptic thermosensitive neurons to locally applied capsaicin. Neuropharmacology, 27, 135-142.
18. JACOBS, B., DRISCOLL, L. & SCHALL, M. (1997). Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative golgi study. J. Comp. Neurol., 386, 661-680.
19. JANSCÓ, G., KIRÁLY, E. & JANSCÓ-GÁBOR, A. (1977). Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature (London), 270, 741-743.
20. KASAI, K., SHENTON, M.E., SALISBURY, D.F., HIRAYASU, Y., ONITSUHA, T., SPENCER, M.H., YURGELUN-TODD, D.A., KIKINIS, R., JOLESZ, F.A. & MCCARLEY, R.W. (2003). Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry, 60, 766-775.
21. KESHAVAN, M.S., DICK, E., MANKWOSKI, I., HARENSKI, K., MONTROSE, D.M., DIWADKAR, V. & DEBELLIS, M. (2002). Decreased left amygdala and hippocampal volumes in young offspring at risk for schizophrenia. Schizophrenia Res., 58, 173-183.
22. KUDOH, A., ISHIHARA, H. & MATSUKI, A. (2000). Current perception thresholds and postoperative pain in schizophrenic patients. Region. Anaesth. Pain Med., 25, 475-479.
23. LEWIS, D.A. & LIEBERMAN, J.A. (2000). Catching up on schizophrenia: natural history and neurobiology. Neuron, 28, 325-334.
24. LIPSKA, B., LERMAN, D., KHAING, Z.Z. & WEINBERGER, D.R. (2003). The neonatal ventral hippocampal lesion model of schizophrenia: effects on dopamine and GABA mRNA markers in the rat midbrain. Eur. J. Neurosci., 18, 3097-3104.
25. MARINELLI, S., VAUGHAN, C.W., CHRISTIE, M.J. & CONNOR, M. (2002). Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. J. Physiol., 543, 531-540.
26. MARINELLI, S., DI MARZO, V., BERRETTA, N., MATIAS, I., MACCARRONE, M., BERNARDI, G. & MERCURI, N.B. (2003). Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J. Neurosci., 23, 3136-3144.
27. MARlNELLI, S., PASCUCCI, T., BERNARDI, G., PUGLISI-ALLEGRA, S. & MERCURI, N.B. (2005). Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens. Neuropsychopharmacology, 30, 864-870.
28. MCCARLEY, R.W., WILBE, C.G., FRUMIN, M., HIRAYASU, Y., LEVITT, J.J., FISCHER, I.A. & SHENTON, M.E. (1999). MRI anatomy of schizophrenia. Biol. Psychiatry, 45, 1099-1119.
29. MCCULLUMSMITH, R.E., CLINTON, S.M. & MEADOR-WOODRUFF, J.H. (2004). Schizophrenia as a disorder of neuroplasticity. Int. Rev. Neurobiol., 59, 19-45.
30. MCDONALD, C., GRECH, A., TOULOPOULOU, T., SCHULZE, K., CHAPPLE, B., SHAM, P., WALSHE, M., SHARMA, T., SIGMUNDSSON, T., CHINTIS, X. & MURRAY, R.M. (2002). Brain volumes in familial and non-familial schizophrenic probands and their unaffected relatives. Am. J. Med. Genet., (Neuropsychiatr. Genet.), 114, 616-625.
31. MESSAMORE, E., HOFFMAN, W.E. & JANOWSKY, A. (2003). The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study. Schizophrenia Res., 62, 251-258.
32. MEZEY, E., TÓTH, Z.E., CORTRIGHT, D.N., ARZUBI, M.K., KRAUSE, J.E., ELDE, R., GUO, A., BLUMBERG, P.M. & SZALLASI, A. (2000). Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. U.S.A., 97, 3655-3660.
33. MOTULSKY, H. (1995). Intuitive Biostatistics. New York, U.S.A.: Oxford University Press.
34. PAXINOS, G. & WATSON, C. (1998). The Rat Brain in Stereotaxic Coordinates, 4th edn. San Diego, CA, U.S.A.: Academic Press.
35. RAJKOWSKA, G., SELEMON, L.D. & GOLDMAN-RAKIC, P.S. (1998). Neuronal and glial somal size in the prefrontal cortex: a post-mortem morphometric study of schizophrenia and Huntington disease. Arch. Gen. Psychiatry, 55, 215-224.
36. REITE, M., TEALE, P., ROJAS, D.C., BENKERS, T.L. & CARLSON, J. (2003). Anomalous somatosensory cortical localisation in schizophrenia. Am. J. Psychiatry, 160, 2148-2153.
37. SADAKA, Y., WEINFELD, E., LEV, D.L. & WHITE, E.L. (2003). Changes in mouse barrel synapses consequent to sensory deprivation from birth. J. Comp. Neurol., 457, 75-86.
38. SASAMURA, T., SASAKI, M., TOHDA, C. & KURAISHI, Y. (1998). Existence of capsaicin-sensitive glutamatergic terminals in rat hypothalamus. NeuroReport, 9, 2045-2048.
39. SELEMON, L.D. & GOLDMAN-RAKIC, P.S. (1999). The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry, 45, 17-25.
40. SELEMON, L.D., RAJKOWSKA, G. & GOLDMAN-RAKIC, P.S. (1995). Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry, 52, 805-820.
41. SELEMON, L.D., RAJKOWSKA, G. & GOLDMAN-RAKIC, P.S. (1998). Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a 3-dimensional, stereologic counting method. J. Comp. Neurol., 392, 402-412.
42. SELEMON, L.D., KLEINMAN, J.E., HERMAN, M.M. & GOLDMAN-RAKIC, P.S. (2002). Smaller frontal gray matter volume in post-mortem schizophrenic brains. Am. J. Psychiatry, 159, 1983-1991.
43. SCHRODER, J., ESSIG, M., BLAUDNENDISTEL, K., JAHN, T., GERDSEN, I., STOCKERT, A., SHAD, L.R. & KNOPP, V. (1999). Motor dysfunction and sensorimotor cortex activation changes in schizophrenia: a study with functional magnetic resonance imaging. Neuroimage, 9, 81-87.
44. SCHLAEPFER, T.E., HARRIS, G.J., TIEN, A.Y., PENG, L.W., LEE, S., FEDERMAN, E.B., CHASE, G.A., BARTA, P.E. & PEARLSON, G.D. (1994). Decreased regional cortical gray matter volume in schizophrenia. Am. J. Psychiatry, 151, 842-848.
45. SCHULTZ, S.K. & ANDREASEN, N.C. (1999). Schizophrenia. Lancet, 353, 1425-1430.
46. SHENTON, M.E., KIKINIS, R., JOLESZ, F.A., POLLAK, S.D., LEMAY, M., WIBLE, C.G., HOKAMA, H., MARTIN, J., METCALF, D., COLEMAN, M. & MCCARLEY, R.W. (1992). Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. New Engl. J. Med., 327, 604-612.
47. SWEET, R.A., BERGEN, S.E., SUN, Z., SAMPSON, A.R., PIERRI, J.N. & LEWIS, D.A. (2004). Pyramidal cell size reduction in schizophrenia: evidence for involvement of auditory feedforward circuits. Biol. Psychiatry, 55, 1128-1137.
48. SZALLASI, A. & BLUMBERG, P.M. (1999). Vanilloid (capsaicin) receptors and mechanisms. Pharmacol. Rev., 51, 159-211.
49. TOLIVIA, J. & TOLIVIA, D. (1985). A new technique for differential and simultaneous staining of nerve cells and fibers. J. Neurosci. Methods, 13, 305-311.
50. TÓTH, A., BOCZÁN, J., KEDEI, N., LIZANECZ, E., BAGI, Z., PAPP, Z., ÉDES, I., CSIBA, L. & BLUMBERG, P.M. (2005). Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Mol. Brain Res., 135, 162-168.
51. VALENZANO, K.J. & SUN, Q. (2004). Current perspectives on the therapeutic utility of VR1 antagonists. Current Med. Chem., 11, 3185-3202.
52. WABERSKI, T.D., NORRA, C., KAWOHL, W., THYERLEI, D., HOCK, D., KLOSTERMANN, F., CURIO, G., BUCHNER, H., HOFF, P. & GOBBELE, R. (2004). Electrophysiological evidence for altered early cerebral somatosensory signal processing in schizophrenia. Psychophysiology, 41, 361-366.
53. WALDO, M.C. (1999). Co-distribution of sensory gating and impaired niacin flush response in the parents of schizophrenics. Schizophrenia Res., 40, 49-53.
54. WEICKERT, T.W., TERRAZAS, A., BIGELOW, L.B., MALLEY, J.D., HYDE, T., EGAN, M.F., WEINBERGER, D.R. & GOLDBERG, T.E. (2002). Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input. Learn. Mem., 9, 430-442.